LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,775 | -99.4% | 79 | -99.5% | 0.00% | -100.0% |
| Q4 2023 | $1,046,946 | -56.6% | 14,659 | -63.6% | 0.00% | -66.7% |
| Q3 2023 | $2,412,020 | +113.8% | 40,254 | +157.3% | 0.01% | +50.0% |
| Q2 2023 | $1,127,932 | +192.2% | 15,644 | +198.1% | 0.00% | +100.0% |
| Q1 2023 | $386,043 | +53.4% | 5,248 | +39.3% | 0.00% | +100.0% |
| Q4 2022 | $251,636 | -63.6% | 3,767 | -53.0% | 0.00% | -75.0% |
| Q3 2022 | $691,000 | -62.9% | 8,022 | -61.6% | 0.00% | -71.4% |
| Q2 2022 | $1,862,000 | +121.9% | 20,871 | +179.8% | 0.01% | +100.0% |
| Q1 2022 | $839,000 | -51.5% | 7,459 | -51.8% | 0.01% | -72.0% |
| Q2 2020 | $1,730,000 | – | 15,468 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
| OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
| Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
| ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
| First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
| Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
| OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
| RK Capital | 127,983 | $13,876,000 | 2.42% |
| Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |